✨ Your Portfolio is fetched and updated from zerodha.

Zim Laboratories Ltd.

ZIMLAB

Market Cap
₹444 Cr.
P/E
28.92

Zim Laboratories Ltd.

  • Zim Laboratories
  • Venus Remedies
  • Lyka Labs
  • TJI Pharma - Small Cap
FAQs on Zim Laboratories Ltd. Shareprice

Zim Laboratories has given lower returns compared to its competitors.
Zim Laboratories has grown at ~14.15% over the last 6yrs while peers have grown at a median rate of 20.69%

Yes, Zim Laboratories is expensive.
Latest PE of Zim Laboratories is 28.94, while 3 year average PE is 27.39.
Also latest EV/EBITDA of Zim Laboratories is 11.98 while 3yr average is 10.52.

View FAQ's On Business
Growth Table
  • Zim Laboratories Ltd.
  • Venus Remedies
  • Lyka Labs
Balance Sheet
  • Zim Laboratories Ltd.
  • Venus Remedies
  • Lyka Labs
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Zim Laboratories Ltd.
  • Venus Remedies
  • Lyka Labs
Cash Flow
  • Zim Laboratories Ltd.
  • Venus Remedies
  • Lyka Labs
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Zim Laboratories Ltd.
  • Venus Remedies
  • Lyka Labs
Quarterly Results
  • Zim Laboratories Ltd.
  • Venus Remedies
  • Lyka Labs
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Zim Laboratories Ltd. Financials

Balance sheet of Zim Laboratories is strong.
But short term working capital might become an issue for this company.

Yes, The debt of Zim Laboratories is increasing.
Latest debt of Zim Laboratories is ₹91.54 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹85.4 Crs.

No, profit is decreasing.
The profit of Zim Laboratories is ₹15.37 Crs for TTM, ₹17.25 Crs for Mar 2024 and ₹24.43 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Zim Laboratories latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly productive assets like Plant & Machinery

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech